206 related articles for article (PubMed ID: 23246967)
1. Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells.
Sarkar S; Brautigan DL; Parsons SJ; Larner JM
Oncogene; 2014 Jan; 33(1):26-33. PubMed ID: 23246967
[TBL] [Abstract][Full Text] [Related]
2. Aurora Kinase A Promotes AR Degradation via the E3 Ligase CHIP.
Sarkar S; Brautigan DL; Larner JM
Mol Cancer Res; 2017 Aug; 15(8):1063-1072. PubMed ID: 28536143
[TBL] [Abstract][Full Text] [Related]
3. PC-1 works in conjunction with E3 ligase CHIP to regulate androgen receptor stability and activity.
Wang J; Zhang H; Zhang X; Wang P; Wang H; Huang F; Zhou C; Zhou J; Li S
Oncotarget; 2016 Dec; 7(49):81377-81388. PubMed ID: 27835608
[TBL] [Abstract][Full Text] [Related]
4. Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.
Steely AM; Willoughby JA; Sundar SN; Aivaliotis VI; Firestone GL
Anticancer Drugs; 2017 Oct; 28(9):1018-1031. PubMed ID: 28708672
[TBL] [Abstract][Full Text] [Related]
5. p21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2).
Liu T; Li Y; Gu H; Zhu G; Li J; Cao L; Li F
J Biol Chem; 2013 Feb; 288(5):3359-69. PubMed ID: 23132866
[TBL] [Abstract][Full Text] [Related]
6. The Steroidogenic Enzyme AKR1C3 Regulates Stability of the Ubiquitin Ligase Siah2 in Prostate Cancer Cells.
Fan L; Peng G; Hussain A; Fazli L; Guns E; Gleave M; Qi J
J Biol Chem; 2015 Aug; 290(34):20865-20879. PubMed ID: 26160177
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer.
Zhang A; Zhao JC; Kim J; Fong KW; Yang YA; Chakravarti D; Mo YY; Yu J
Cell Rep; 2015 Oct; 13(1):209-221. PubMed ID: 26411689
[TBL] [Abstract][Full Text] [Related]
8. Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer.
Liu C; Lou W; Yang JC; Liu L; Armstrong CM; Lombard AP; Zhao R; Noel ODV; Tepper CG; Chen HW; Dall'Era M; Evans CP; Gao AC
Nat Commun; 2018 Nov; 9(1):4700. PubMed ID: 30446660
[TBL] [Abstract][Full Text] [Related]
9. Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity.
Vummidi Giridhar P; Williams K; VonHandorf AP; Deford PL; Kasper S
Cancer Res; 2019 Mar; 79(6):1124-1137. PubMed ID: 30626627
[TBL] [Abstract][Full Text] [Related]
10. Zipper-interacting protein kinase is involved in regulation of ubiquitination of the androgen receptor, thereby contributing to dynamic transcription complex assembly.
Felten A; Brinckmann D; Landsberg G; Scheidtmann KH
Oncogene; 2013 Oct; 32(41):4981-8. PubMed ID: 23146908
[TBL] [Abstract][Full Text] [Related]
11. RING finger protein 31 promotes p53 degradation in breast cancer cells.
Zhu J; Zhao C; Zhuang T; Jonsson P; Sinha I; Williams C; Strömblad S; Dahlman-Wright K
Oncogene; 2016 Apr; 35(15):1955-64. PubMed ID: 26148235
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of androgen receptor by PIM-1 kinases via phosphorylation-dependent recruitment of distinct ubiquitin E3 ligases.
Linn DE; Yang X; Xie Y; Alfano A; Deshmukh D; Wang X; Shimelis H; Chen H; Li W; Xu K; Chen M; Qiu Y
J Biol Chem; 2012 Jun; 287(27):22959-68. PubMed ID: 22584579
[TBL] [Abstract][Full Text] [Related]
13. Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy.
Liao Y; Liu Y; Xia X; Shao Z; Huang C; He J; Jiang L; Tang D; Liu J; Huang H
Theranostics; 2020; 10(8):3366-3381. PubMed ID: 32206096
[No Abstract] [Full Text] [Related]
14. C-terminal Hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation.
Cardozo CP; Michaud C; Ost MC; Fliss AE; Yang E; Patterson C; Hall SJ; Caplan AJ
Arch Biochem Biophys; 2003 Feb; 410(1):134-40. PubMed ID: 12559985
[TBL] [Abstract][Full Text] [Related]
15. Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway.
Deep G; Oberlies NH; Kroll DJ; Agarwal R
Oncogene; 2008 Jun; 27(28):3986-98. PubMed ID: 18332867
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase.
Lin HK; Wang L; Hu YC; Altuwaijri S; Chang C
EMBO J; 2002 Aug; 21(15):4037-48. PubMed ID: 12145204
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor primes prostate cancer cells to apoptosis through down-regulation of basal p21 expression.
Lin Y; Lu Z; Kokontis J; Xiang J
Biochem Biophys Res Commun; 2013 Jan; 430(1):289-93. PubMed ID: 23159636
[TBL] [Abstract][Full Text] [Related]
18. DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor.
Jing Y; Nguyen MM; Wang D; Pascal LE; Guo W; Xu Y; Ai J; Deng FM; Masoodi KZ; Yu X; Zhang J; Nelson JB; Xia S; Wang Z
Oncogene; 2018 Feb; 37(5):638-650. PubMed ID: 28991234
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Highly Potent and Efficient PROTAC Degraders of Androgen Receptor (AR) by Employing Weak Binding Affinity VHL E3 Ligase Ligands.
Han X; Zhao L; Xiang W; Qin C; Miao B; Xu T; Wang M; Yang CY; Chinnaswamy K; Stuckey J; Wang S
J Med Chem; 2019 Dec; 62(24):11218-11231. PubMed ID: 31804827
[TBL] [Abstract][Full Text] [Related]
20. 2-methoxyestradiol blocks cell-cycle progression at G(2)/M phase and inhibits growth of human prostate cancer cells.
Kumar AP; Garcia GE; Slaga TJ
Mol Carcinog; 2001 Jul; 31(3):111-24. PubMed ID: 11479920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]